WallStreetZenWallStreetZen

NASDAQ: QLGN
Qualigen Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their QLGN stock forecasts and price targets.

Forecast return on equity

Is QLGN forecast to generate an efficient return?

Forecast return on assets

Is QLGN forecast to generate an efficient return on assets?
Company
-2,171.48%
Industry
-0.61%
QLGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QLGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QLGN$0.30N/AN/A
BPTH$2.64$40.00+1,418.03%Strong Buy
SCNI$0.45N/AN/A
GLMD$0.39N/AN/A
NBSE$0.44N/AN/A

Qualigen Therapeutics Stock Forecast FAQ

What is QLGN's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: QLGN) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Qualigen Therapeutics stock.

What is QLGN's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: QLGN) forecast ROA is -2,171.48%, which is lower than the forecast US Biotechnology industry average of -0.61%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.